CCL2 and Parkinson disease: Chemokines, such as monocyte chemoattractant protein-1 (MCP-1) and CX3CL1 (fractalkine), further contribute to the recruitment and activation of peripheral immune cells, especially when the blood–brain barrier (BBB) is compromised, a common feature in PD [78].